The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

Investors soured on the sector when Elevance, an insurer, handed in disappointing results and shared a downbeat outlook.

Now, it’s worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

One of the big reasons to like Pfizer (NYSE: PFE) today is its huge 7.1% dividend yield. Pfizer competitor Merck (NYSE: MRK) ...

A strong medical technology segment and an expanding pharmaceutical business could keep pushing ... Learn More » Image source ...

Before you invest in pharmaceutical companies, find out some top picks and learn how to choose the best stocks in the pharmaceutical sector. Image source: Getty Images.

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach to drug discovery driven by AI and ...

In the past two years, Lilly stock is over 193% higher, and the S&P 500 has gained 45% or so. Analysts see shares rising 11.0% in the next year to their mean price target of $1,003.35.